Thanks to C-CAMP, Japanese VC firm to invest $5 million for Indian bioscience startups

Bengaluru: The Centre for Cellular and Molecular Platforms (C-CAMP), India’s premier bio-innovation hub recently signed a letter of intent (LOI) with Beyond Next Ventures (BNV), one of the leading independent accelerators in Japan dedicated to incubation investment in technology start-ups.

The broad aim of this collaboration is to encourage and promote the best deep science innovations in the field of Life Sciences and Biotechnology in India. The two organizations intend to create the C-CAMP – BNV Innovation Hub (CBIH) which will largely focus on facilitating Japanese investment of up to 5 million USD in Indian start-ups working on exciting technologies in the life sciences and biotech domain. This hub also aims to support start-ups in both the regions through the exchange of human resources and technologies and through other facilitation programs and events to connect skilled talent, entrepreneurs and other stakeholders in both regions.

In his comments, Dr Taslimarif Saiyed, CEO and Director, C-CAMP said, “C-CAMP has been identifying and supporting the most exciting early stage innovations and now looks forward to nurture many more such high-risk high-return innovations at an early stage through this collaboration with Beyond Next Ventures. This will be a fantastic start to build Indo-Japan collaborations for high-end innovations.”

Mr Tsuyoshi Ito CEO, BNV mentioned, “We are very excited to jointly launch the “C-CAMP Beyond Next Ventures Innovation Hub” (“CBIH”) in collaboration with the top incubator in India C-CAMP. As the top accelerator and VC in Japan, we look forward to combining our experience and extensive network with C-CAMP to support new innovations in Japan and India. Through this collaboration, we plan to make full-fledged venture investments into the life sciences field of India and contribute to the industrial and economic development in India in the future.”